Home / Insulin Aspart / Austria
AT ATC A10AB05 · updated 2 Nov 2026
Insulin Aspart shortage in Austria
Is there an Insulin Aspart shortage in Austria?
Yes. As of 2 Nov 2026, 1 Insulin Aspart product is reported short in Austria, the first since 15 Sep 2025. The company estimate for the return is 31 Jul 2027. Main reason: manufacturing problem.
Also short in Canada, Germany, Spain, Norway, Sweden. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | NovoRapid PumpCart 100 Einheiten/ml Injektionslösung in einer Patrone, 5 Stück limited | Novo Nordisk A/S | 15 Sep 2025 | 31 Jul 2027 | Manufacturing problem Kapazitätsengpässe bei der Herstellung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).